Daniel H. Kwon

1.6k total citations
40 papers, 357 citations indexed

About

Daniel H. Kwon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel H. Kwon has authored 40 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel H. Kwon's work include Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Daniel H. Kwon is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Daniel H. Kwon collaborates with scholars based in United States, Canada and South Korea. Daniel H. Kwon's co-authors include Eric J. Small, Hala T. Borno, Paul Y. Kwo, Gary Tse, Heather H. Cheng, Justin R. Tse, Alicia Y. Zhou, Tahereh Ghaziani, Andrew Kesselman and Aya Kamaya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Daniel H. Kwon

33 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel H. Kwon United States 10 122 95 90 77 58 40 357
Louis Cai United States 8 90 0.7× 27 0.3× 101 1.1× 128 1.7× 86 1.5× 26 404
Andrew Ip United States 8 196 1.6× 58 0.6× 83 0.9× 32 0.4× 11 0.2× 66 415
Jeremy Chang United States 9 151 1.2× 30 0.3× 51 0.6× 23 0.3× 16 0.3× 25 343
Monika Sobočan Slovenia 13 62 0.5× 26 0.3× 102 1.1× 28 0.4× 9 0.2× 47 423
Linye He China 10 98 0.8× 25 0.3× 75 0.8× 18 0.2× 14 0.2× 16 435
Lynn Tran United States 10 32 0.3× 40 0.4× 71 0.8× 45 0.6× 10 0.2× 24 352
Jared D. Acoba United States 12 171 1.4× 50 0.5× 80 0.9× 19 0.2× 5 0.1× 39 345
Azim Mehrvar Iran 12 92 0.8× 43 0.5× 44 0.5× 29 0.4× 7 0.1× 63 417
Basil K. Williams United States 13 76 0.6× 30 0.3× 92 1.0× 122 1.6× 4 0.1× 64 510

Countries citing papers authored by Daniel H. Kwon

Since Specialization
Citations

This map shows the geographic impact of Daniel H. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Kwon more than expected).

Fields of papers citing papers by Daniel H. Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Kwon. The network helps show where Daniel H. Kwon may publish in the future.

Co-authorship network of co-authors of Daniel H. Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Kwon. A scholar is included among the top collaborators of Daniel H. Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Kwon. Daniel H. Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwon, Daniel H., Maren T. Scheuner, Evan J. Walker, et al.. (2025). Veterans' Decision Making for Prostate Cancer Germline Testing After Informed Consent With Their Oncologist: A Mixed-Methods Study. JCO Oncology Practice. 22(3). 502–515.
2.
3.
Kwon, Daniel H., Maren T. Scheuner, Evan J. Walker, et al.. (2024). Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits. JNCI Cancer Spectrum. 8(5). 1 indexed citations
4.
Kwon, Daniel H., Hala T. Borno, Rohit Bose, et al.. (2024). Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer. Cancer Medicine. 13(22). e70433–e70433.
5.
Desai, Arpita, et al.. (2024). Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment. Urologic Oncology Seminars and Original Investigations. 42(11). 375.e1–375.e13.
6.
7.
Kwon, Daniel H., Tahereh Ghaziani, Paul Y. Kwo, et al.. (2024). Large language models’ responses to liver cancer surveillance, diagnosis, and management questions: accuracy, reliability, readability. Abdominal Radiology. 49(12). 4286–4294. 15 indexed citations
8.
Kwon, Daniel H., et al.. (2023). FDG PET Scans in Cancer Care. JAMA Oncology. 9(9). 1304–1304. 3 indexed citations
9.
Kwon, Daniel H., Hala T. Borno, Rahul Aggarwal, et al.. (2023). Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer. JCO Oncology Practice. 19(5). e773–e783. 9 indexed citations
10.
Zhu, Xiaolin, Li Zhang, Kevin Reyes, et al.. (2023). Association of biomarkers and response to immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) with high and low tumor mutation burden (TMB).. Journal of Clinical Oncology. 41(6_suppl). 534–534. 2 indexed citations
11.
Reyes, Kevin, Li Zhang, Xiaolin Zhu, et al.. (2023). Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 41(6_suppl). 532–532. 3 indexed citations
12.
Kwon, Daniel H., Julian C. Hong, Osama Mohamad, et al.. (2022). Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urologic Oncology Seminars and Original Investigations. 41(3). 145.e7–145.e15. 2 indexed citations
13.
Kwon, Daniel H., Alan Paciorek, Li Zhang, et al.. (2022). Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset. Urologic Oncology Seminars and Original Investigations. 40(8). 379.e17–379.e24. 2 indexed citations
14.
Kwon, Daniel H., José Cadena, Braden Soper, et al.. (2022). COVID ‐19 outcomes in patients with cancer: Findings from the University of California health system database. Cancer Medicine. 11(11). 2204–2215. 4 indexed citations
15.
Kwon, Daniel H., Rohit Vashisht, Hala T. Borno, et al.. (2021). Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry. Annals of Oncology. 32(5). 678–679. 11 indexed citations
16.
Velázquez, Ana I., et al.. (2020). Abstract C043: Ethnic disparities among pancreatic cancer patients undergoing germline testing. Cancer Epidemiology Biomarkers & Prevention. 29(6_Supplement_2). C043–C043. 2 indexed citations
17.
Park, Jinny, et al.. (2020). Low-dose Methotrexate Treatment for Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma: A Long-term Follow-up Study. Acta Dermato Venereologica. 100(4). 0–0. 1 indexed citations
18.
Kwon, Daniel H., Hala T. Borno, Heather H. Cheng, Alicia Y. Zhou, & Eric J. Small. (2019). Ethnic disparities among men with prostate cancer undergoing germline testing. Urologic Oncology Seminars and Original Investigations. 38(3). 80.e1–80.e7. 47 indexed citations
19.
Kwon, Daniel H., et al.. (2017). Gastric neuroendocrine tumors: management and challenges. Volume 7. 31–37. 5 indexed citations
20.
Kwon, Daniel H.. (2001). Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis. Journal of Neuroimmunology. 113(1). 1–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Cai Breakdown of academic impact, for papers by Andrew Ip Breakdown of academic impact, for papers by Jeremy Chang Breakdown of academic impact, for papers by Monika Sobočan Breakdown of academic impact, for papers by Linye He Breakdown of academic impact, for papers by Lynn Tran Breakdown of academic impact, for papers by Jared D. Acoba Breakdown of academic impact, for papers by Azim Mehrvar Breakdown of academic impact, for papers by Basil K. Williams
Rankless by CCL
2026